FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans-Peter Beck-Bornholdt

Research Profile

Disorders

Living Beings

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Sven Anders; Axel Gehl; Michaela Kunz; Tobias Raupach; Susanne Sehner; Hans-Peter Beck-Bornholdt
Estimation of the time since death--reconsidering the re-establishment of rigor mortis.
Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
Systematic review of publication bias in studies on publication bias.
Hanna Kaduszkiewicz; Thomas Zimmermann; Hans-Peter Beck-Bornholdt; Hendrik van den Bussche
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans-Peter Beck-Bornholdt (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sven Anders; Axel Gehl; Michaela Kunz; Tobias Raupach; Susanne Sehner; Hans-Peter Beck-Bornholdt
Estimation of the time since death--reconsidering the re-establishment of rigor mortis.
International journal of legal medicine 2013;127(1):127-30.
2005: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
Systematic review of publication bias in studies on publication bias.
BMJ (Clinical research ed.) 2005;331(7514):433-4.
2005: Hanna Kaduszkiewicz; Thomas Zimmermann; Hans-Peter Beck-Bornholdt; Hendrik van den Bussche
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
BMJ (Clinical research ed.) 2005;331(7512):321-7.
2004: Hanna Kaduszkiewicz; Hans-Peter Beck-Bornholdt; Hendrik van den Bussche; Thomas Zimmermann
[Doubtful evidence for the use of the cholinesterase inhibitor donepezil in patients with dementia--a systematic review].
Fortschritte der Neurologie-Psychiatrie 2004;72(10):557-63.
2004: Maike de Wit; Annette Raabe; B Seegers; Ralph Buchert; Hans-Peter Beck-Bornholdt; Winfried Alberti; Dieter K Hossfeld
Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
International journal of radiation biology 2004;80(7):529-39.
2001: Horst Jung; Hans-Peter Beck-Bornholdt; V Svoboda; Winfried Alberti; T Herrmann
Quantification of late complications after radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;61(3):233-46.
2001: JO Zieron; M Omniczynski; Annette Raabe; Hans-Peter Beck-Bornholdt
Impact of the position of a gap on the response of the R1H-tumor of the rat on fractionated split-course radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(11):592-6.
2001: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt; A Schmidt
[Authorship of scientific publications. Audit of the periodical "Strahlentherapie und Onkologie"].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(10):547-53.
2001: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
International journal of radiation oncology, biology, physics 2001;51(2):563.
2001: Annette Raabe; Hans-Peter Beck-Bornholdt; Andreas Krüll; JO Zieron; Winfried Alberti
Impact of pulmonary metastases of the R1H-tumour on radiation tolerance of rat lung.
International journal of radiation biology 2001;77(9):947-54.
2001: Annette Raabe; S Quaester; Hans-Hermann Dubben; JO Zieron; Andreas Krüll; Winfried Alberti; Hans-Peter Beck-Bornholdt
Impact of treatment acceleration and its timing on the response of the rhabdomyosarcoma R1H of the rat to fractionated irradiation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(7):362-6.
2001: Hans-Hermann Dubben; Andreas Krüll; Hans-Peter Beck-Bornholdt
Split-course radiotherapy: where do we stand?
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(5):227-39.
2000: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
[Actuarial analysis of time-failure data and its rrelevance for interpretation of results. Audit of the journal "Strahlentherapie und Onkologie" (Radiotherapy and Oncology)].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(12):547-54.
2000: Annette Raabe; Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
[Type two error and its relevance for interpretation of results. Quality audit of the Journal "Strahlentherapie und Onkologie].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(11):491-7.
2000: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
[Multiple significance tests and their importance in the judging of results. A quality analysis of the journal Strahlentherapie und Onkologie].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(8):344-9.
2000: Annette Raabe; S Eickhölter; JO Zieron; Andreas Krüll; Hans-Peter Beck-Bornholdt; Winfried Alberti
Influence of dose per fraction and overall treatment time on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;56(2):259-64.
2000: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
[Confidence intervals and their relevance for the interpretation of results. Audit of the journal "Strahlentherapie und Onkology"].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(5):205-10.
1999: V Svoboda; Hans-Peter Beck-Bornholdt; T Herrmann; Winfried Alberti; Horst Jung
Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;53(3):177-87.
1999: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
[What is power and why specifically 80%?].
Medizinische Klinik (Munich, Germany : 1983) 1999;94 Suppl 2():5-7.
1999: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
[What is p and why specifically 0.05?].
Medizinische Klinik (Munich, Germany : 1983) 1999;94 Suppl 2():3-4.
1999: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
[What is power and why calculated at 80%?].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175 Suppl 1():5-7.
1999: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
[What is p and why calculated at 0.05?].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175 Suppl 1():3-4.
1998: Hans-Hermann Dubben; H D Thames; Hans-Peter Beck-Bornholdt
Tumor volume: a basic and specific response predictor in radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;47(2):167-74.
1998: Günter-Willi Fröschle; JO Zieron; U M Carl; Hans-Peter Beck-Bornholdt
Combined modality treatment of bone metastases: response of the rhabdomyosarcoma R1H of the rat to postoperative irradiation combined with local release of daunorubicin from acrylic cement.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(3):317-20.
1998: Henning Willers; HP Heilmann; Hans-Peter Beck-Bornholdt
[One hundred years of radiotherapy. Historical origins and development of fractionated irradiation in German speaking countries].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174(2):53-63.
1998: Henning Willers; C Liertz-Petersen; Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
Outcome of hyperfractionated radiation therapy in randomized clinical trials.
International journal of radiation oncology, biology, physics 1998;40(1):257-9.
1997: Annette Raabe; M Rett; Andreas Krüll; Hans-Peter Beck-Bornholdt
Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(2):183-9.
1997: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
[Dose fractionation in radiotherapy].
Klinische Monatsblätter für Augenheilkunde 1997;211(4):aA11-aA13.
1997: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben; Henning Willers
[Proliferation rate and radiosensitivity. Bergonié's and Tribondeau's error].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(6):335-7.
1997: Henning Willers; B Prosch; Hans-Peter Beck-Bornholdt
Impact of the interfraction interval on clonogenic cell survival in split-dose irradiation of R1H rhabdomyosarcoma of the rat in vitro.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(1):93-6.
1997: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben; C Liertz-Petersen; Henning Willers
Hyperfractionation: where do we stand?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(1):1-21.
1997: U M Carl; P Sminia; J Bahnsen; Günter-Willi Fröschle; M Omniczynski; L Wolf; U Krüger; K A Hartmann; Hans-Peter Beck-Bornholdt
Post-Operative Radiotherapy of the Rhabdomyosarcoma R1H of the Rat.
Sarcoma 1997;1(3-4):143-7.
1996: Henning Willers; Hans-Peter Beck-Bornholdt
[Historical experiences in trying different overall treatment times in x-ray therapy of malignant head and neck tumors in the 1920s and 1930s].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1996;172(9):512-5.
1996: Henning Willers; Hans-Peter Beck-Bornholdt
Origins of radiotherapy and radiobiology: separation of the influence of dose per fraction and overall treatment time on normal tissue damage by Reisner and Miescher in the 1930s.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(2):171-3.
1996: A Raabe; Hans-Peter Beck-Bornholdt
The possible influence of breathing patterns on the measurements of breathing frequency.
Radiation research 1996;145(2):236-8.
1995: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
Prediction of normal-tissue tolerance from in vitro cellular radiation sensitivity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;36(3):245-6.
1995: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
[Mathematical models and computer simulations--a useful tool or confusing fooling around?].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(8):473-4.
1995: F Würschmidt; Hans-Peter Beck-Bornholdt
Combined modality treatment of the rhabdomyosarcoma R1H of the rat: tumor and normal tissue response after cisplatin and conventional or accelerated irradiation treatment.
International journal of radiation oncology, biology, physics 1995;32(2):391-4.
1995: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
Rebuttal: is gambling a serious alternative to evidence-based medicine?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):161-2.
1994: M Baumann; F Würschmidt; A Twardy; Hans-Peter Beck-Bornholdt
Impact of tumor stroma on expression of the tumor bed effect in R1H rat rhabdomyosarcoma.
Radiation research 1994;140(3):432-6.
1994: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
Potential pitfalls in the use of p-values and in interpretation of significance levels.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(2):171-6.
1994: Hans-Peter Beck-Bornholdt; M Baumann; T Herrmann; M Molls; R Sauer; K R Trott
[Problems of radiotherapy in Germany after the recent events in Hamburg].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(8):486-91.
1994: F Würschmidt; H Bünemann; C Bünemann; Hans-Peter Beck-Bornholdt; HP Heilmann
[The radiotherapy of inoperable non-small-cell bronchial carcinoma. A retrospective analysis of 427 cases].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(5):302-4.
1994: Hans-Peter Beck-Bornholdt; M Kleineidam; A Pieconka
[The effect of the time interval between fractions on the result of a fractionated irradiation of the R1H tumor].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(4):232-4.
1994: A Raabe; Hans-Peter Beck-Bornholdt
Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H tumour.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):254-62.
1994: M Kleineidam; A Pieconka; Hans-Peter Beck-Bornholdt
Radiotherapy of the rhabdomyosarcoma R1H of the rat: influence of the time interval between two daily fractions during hyperfractionated radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(2):128-32.
1994: F Würschmidt; H Bünemann; C Bünemann; Hans-Peter Beck-Bornholdt; HP Heilmann
Inoperable non-small cell lung cancer: a retrospective analysis of 427 patients treated with high-dose radiotherapy.
International journal of radiation oncology, biology, physics 1994;28(3):583-8.
1994: A Raabe; Hans-Peter Beck-Bornholdt
[Growth and radiosensitivity of pulmonary micrometastases in the R1H-tumor of the rat].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(2):111-5.
1993: Peter Sminia; Ulrich M Carl; M Omniczynski; W Jansen; K Meisner; Hans-Peter Beck-Bornholdt
Long-term observation of the rat skin after fractionated local X irradiation: development of secondary tumors.
Radiation research 1993;136(2):222-8.
1993: M Kleineidam; R Guthoff; F Schiller; L Chumbley; Hans-Peter Beck-Bornholdt
Radiotherapy of the R1H-tumor: dose-rate effect on tumor response in brachytherapy with 106-ruthenium eye applicators.
International journal of radiation oncology, biology, physics 1993;25(2):277-81.
1993: Hans-Hermann Dubben; Hans-Peter Beck-Bornholdt
Influence of the timing of a concomitant boost during fractionated irradiation of rat rhabdomyosarcoma R1H.
Acta oncologica (Stockholm, Sweden) 1993;32(1):79-82.
1993: Hans-Peter Beck-Bornholdt
Quantification of relative biological effectiveness, dose modification factor and therapeutic gain factor.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1993;169(1):42-7.
1992: Hans-Hermann Dubben; M Baumann; T Fassbender; Hans-Peter Beck-Bornholdt
[The hyperfractionated radiotherapy of tumors in the head-neck area].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1992;168(7):373-82.
1992: Ingo Brammer; F Zywietz; Hans-Peter Beck-Bornholdt; H Jung
Kinetics of depopulation, repopulation and host cell infiltration in the rhabdomyosarcoma R1H after 14 MeV neutron irradiation.
International journal of radiation biology 1992;61(5):703-11.
1992: F Würschmidt; S Becker; T Maurer; M Omniczynski; R Schelp; H Vogler; Hans-Peter Beck-Bornholdt
Radiotherapy of the rhabdomyosarcoma R1H of the rat: recovery from radiation injury in tumour and skin.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;23(2):105-10.
1992: T Fassbender; Hans-Peter Beck-Bornholdt
[The experimental brachytherapy of rhabdomyosarcoma R1H in the rat with iodine-125 seeds].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1992;168(1):48-52.
1992: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
Experience with continuous hyperfractionated accelerated radiotherapy (CHART)
International journal of radiation oncology, biology, physics 1992;23(3):678-9.
1992: Hans-Peter Beck-Bornholdt; Hans-Hermann Dubben
Oxygen enhancement ratio of a murine fibrosarcoma.
International journal of radiation oncology, biology, physics 1992;24(4):805-6.
1991: Hans-Peter Beck-Bornholdt
Should tumors be clamped in radiobiological fractionation experiments?
International journal of radiation oncology, biology, physics 1991;21(3):675-82.
1991: Hans-Peter Beck-Bornholdt; M Baumann; Hans-Hermann Dubben; F Würschmidt; M F Harvey
The hazard of short overall treatment times in radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20(1):66-8.
1991: Hans-Peter Beck-Bornholdt; M Omniczynski; E Theis; H Vogler; F Würschmidt
Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation.
Acta oncologica (Stockholm, Sweden) 1991;30(1):57-63.
1991: F Würschmidt; Hans-Peter Beck-Bornholdt; H Vogler; H Jung
Radiotherapy of the rhabdomyosarcoma R1H of the rat: split-course versus continuous fractionation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1991;167(1):26-30.
1991: R Guthoff; M Kleineidam; L Chumbley; F Schiller; Hans-Peter Beck-Bornholdt
[Effect of dose rate of ruthenium 106 plaques on tumor regression in the animal model].
Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 1991;88(6):648-50.
1990: F Milewsky; T Fassbender; F Würschmidt; Hans-Peter Beck-Bornholdt
A simple experimental technique for interstitial iridium-192 high dose-rate afterloading.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1990;166(9):588-90.
1990: M Baumann; S Becker; H J Krüger; H Vogler; T Maurer; Hans-Peter Beck-Bornholdt
Flow cytometric determination of the time of metastasis during fractionated radiation therapy of the rat rhabdomyosarcoma R1H.
International journal of radiation biology 1990;58(2):361-9.
1990: Ulrich M Carl; Hans-Peter Beck-Bornholdt; M Baumann; J Lorenzen; H Vogler
Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy.
International journal of radiation oncology, biology, physics 1990;18(4):883-6.
1990: F Würschmidt; Hans-Peter Beck-Bornholdt; H Vogler
Radiobiology of the rhabdomyosarcoma R1H of the rat: influence of the size of irradiation field on tumor response, tumor bed effect, and neovascularization kinetics.
International journal of radiation oncology, biology, physics 1990;18(4):879-82.
1990: H Jung; H J Krüger; Ingo Brammer; F Zywietz; Hans-Peter Beck-Bornholdt
Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays.
International journal of radiation biology 1990;57(3):567-89.
1989: Hans-Peter Beck-Bornholdt; T Maurer; S Becker; M Omniczynski; H Vogler; F Würschmidt
Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation--126 fractions applied within 6 weeks.
International journal of radiation oncology, biology, physics 1989;16(3):701-5.
1988: F Würschmidt; H Vogler; Hans-Peter Beck-Bornholdt
Radiotherapy of the rhabdomyosarcoma R1H of the rat: the influence of the number of fractions on tumor and skin response.
International journal of radiation oncology, biology, physics 1988;14(3):497-502.
1988: Hans-Peter Beck-Bornholdt
Parameters affecting the response of experimental tumours to fractionated radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1988;164(3):155-64.
1988: H Vogler; Hans-Peter Beck-Bornholdt
Radiotherapy of the rhabdomyosarcoma R1H of the rat: kinetics of cellular inactivation by fractionated irradiation.
International journal of radiation oncology, biology, physics 1988;14(2):317-25.
1987: Hans-Peter Beck-Bornholdt; F Würschmidt; H Vogler
Net growth delay: a novel parameter derived from tumor growth curves.
International journal of radiation oncology, biology, physics 1987;13(5):773-7.